By: Emily Smith March 25, 2021
The coronavirus pandemic has impacted the lives of millions around the world. As mask wearing and social distancing have become an everyday occurrence, people around the world have been hopeful for a return to normalcy.
The pandemic has ignited immense global cooperation in vaccine research and development. The rapid vaccine development did create public concern regarding the safety of vaccines.
With increased reports of blot clotting after covid-19 vaccinations, over a dozen European countries have halted the rollout of the Oxford-AstraZeneca vaccine shots, including the United Kingdom, where 11 million doses have already been administered.
These governmental decisions have sparked controversy, as the vaccine has been proven to reduce Covid-19 cases. For instance, Michael Head, senior research fellow in Global Health at the University of Southampton stated, “These vaccines are to protect against a pandemic virus. There is an urgency to the rollout… So pausing a vaccine campaign without a very good reason at this point in time just seems like a bad move.”
With the lack of hard evidence linking blood clotting to the vaccine, it is interesting the government would decide to put it to a halt. This decision not only increases public concern about their safety but it also makes people wonder wether the government and health officials are properly working together.